EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study

Geraldine Kauma iD, Henry Ddungu iD, Isaac Ssewanyana, Sharon Nyesiga iD, Naghib Bogere iD, Teddy Namulema-Diiro, Pauline Byakika-Kibwika iD, Elizabeth Namukwaya iD, Harriet Mayanja Kizza

JCO Global Oncology · 2023

DOI: 10.1200/go.22.00262 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JCO Global Oncology, 2023. Verfasst von Geraldine Kauma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Uganda Cancer Institute, Kampala, Uganda. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Anti-HIV Agents, Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE AIDS-related mortality declined markedly since the introduction of antiretroviral therapy (ART); however, cancer mortality in Africa was higher than its incidence in 2020. People living with HIV (PLWHIV) are at an increased risk of malignancy and death from malignancy compared with the general population. In Uganda, AIDS-defining malignancies (ADMs), including cervical cancer, Kaposi sarcoma, and non-Hodgkin lymphoma, are among the commonest malignancies. Virologic nonsuppression has been identified as an important predictor of mortality among PLWHIV diagnosed with cancer. This study aimed to determine the prevalence and to identify factors associated with virologic nonsuppression among PLWHIV newly diagnosed with cancer. METHODS This was a cross-sectional study that was carried out between December 2018 and April 2019 at the Uganda Cancer Institute. PLWHIV who had been on ART for at least 6 months and were newly diagnosed with cancer were enrolled. RESULTS A total of 167 participants were enrolled. Cervical cancer was the commonest ADM (n = 45; 50.6%) of all ADMs, while esophageal and breast cancers were the commonest non-ADMs, accounting for 17.5% (n = 14) each of all non-ADMs. The prevalence of virologic nonsuppression was 15%. Having Kaposi sarcoma (odds ratio [OR], 8.15; P = .003), being poorly adherent to ART (OR, 4.1; P = .045), and being on second-line ART (OR, 5.68; P = .011) were associated with virologic nonsuppression. CONCLUSION The prevalence of virologic nonsuppression is high among patients with HIV newly diagnosed with cancer. These findings emphasize the need for strengthening of adherence strategies, optimizing ART regimens, and prioritization of viral load testing among PLWHIV with newly diagnosed malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiAnti-HIV AgentsAcquired Immunodeficiency SyndromeUterine Cervical NeoplasmsHIV InfectionsFemaleHumansCross-Sectional StudiesUganda

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Uganda Cancer Institute, Kampala, Uganda.
  • Uganda Central Public Health Laboratory, Kampala, Uganda.
  • Uganda Heart Institute, Kampala, Uganda.
  • Victorville Clinic Gayaza, Wakiso, Uganda.
  • Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

ORCID-Profile: Geraldine Kauma, Henry Ddungu, Sharon Nyesiga, Naghib Bogere, Pauline Byakika-Kibwika, Elizabeth Namukwaya

Zitieren

APA

Kauma, G., Ddungu, H., Ssewanyana, I., Nyesiga, S., Bogere, N., Namulema-Diiro, T., Byakika-Kibwika, P., Namukwaya, E., & Kizza, H. M. (2023). Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study. JCO Global Oncology. https://doi.org/10.1200/go.22.00262

Vancouver

Kauma G, Ddungu H, Ssewanyana I, Nyesiga S, Bogere N, Namulema-Diiro T, et al. Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study. JCO Global Oncology. 2023. doi:10.1200/go.22.00262

BibTeX
@article{Kauma2023,
  author = {Kauma, Geraldine and Ddungu, Henry and Ssewanyana, Isaac and Nyesiga, Sharon and Bogere, Naghib and Namulema-Diiro, Teddy and Byakika-Kibwika, Pauline and Namukwaya, Elizabeth and Kizza, Harriet Mayanja},
  title = {Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study},
  journal = {JCO Global Oncology},
  year = {2023},
  doi = {10.1200/go.22.00262}
}
Kostenlos starten →